These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Infection-Induced Resistance to Experimental Cerebral Malaria Is Dependent Upon Secreted Antibody-Mediated Inhibition of Pathogenic CD8 Shaw TN; Inkson CA; Villegas-Mendez A; Pattinson DJ; Strangward P; Else KJ; Draper SJ; Zeef LAH; Couper KN Front Immunol; 2019; 10():248. PubMed ID: 30846985 [TBL] [Abstract][Full Text] [Related]
25. Tumor-intrinsic IFNα and CXCL10 are critical for immunotherapeutic efficacy by recruiting and activating T lymphocytes in tumor microenvironment. Cheng CC; Chang J; Ho AS; Sie ZL; Peng CL; Wang CL; Dev K; Chang CC Cancer Immunol Immunother; 2024 Jul; 73(9):175. PubMed ID: 38953994 [TBL] [Abstract][Full Text] [Related]
28. CD8+ T cells and IFN-γ mediate the time-dependent accumulation of infected red blood cells in deep organs during experimental cerebral malaria. Claser C; Malleret B; Gun SY; Wong AY; Chang ZW; Teo P; See PC; Howland SW; Ginhoux F; Rénia L PLoS One; 2011 Apr; 6(4):e18720. PubMed ID: 21494565 [TBL] [Abstract][Full Text] [Related]
30. Verteporfin Inhibits PD-L1 through Autophagy and the STAT1-IRF1-TRIM28 Signaling Axis, Exerting Antitumor Efficacy. Liang J; Wang L; Wang C; Shen J; Su B; Marisetty AL; Fang D; Kassab C; Jeong KJ; Zhao W; Lu Y; Jain AK; Zhou Z; Liang H; Sun SC; Lu C; Xu ZX; Yu Q; Shao S; Chen X; Gao M; Claret FX; Ding Z; Chen J; Chen P; Barton MC; Peng G; Mills GB; Heimberger AB Cancer Immunol Res; 2020 Jul; 8(7):952-965. PubMed ID: 32265228 [TBL] [Abstract][Full Text] [Related]
31. Damage to the blood-brain barrier during experimental cerebral malaria results from synergistic effects of CD8+ T cells with different specificities. Poh CM; Howland SW; Grotenbreg GM; Rénia L Infect Immun; 2014 Nov; 82(11):4854-64. PubMed ID: 25156726 [TBL] [Abstract][Full Text] [Related]
32. Gamma Interferon Mediates Experimental Cerebral Malaria by Signaling within Both the Hematopoietic and Nonhematopoietic Compartments. Villegas-Mendez A; Strangward P; Shaw TN; Rajkovic I; Tosevski V; Forman R; Muller W; Couper KN Infect Immun; 2017 Nov; 85(11):. PubMed ID: 28874445 [TBL] [Abstract][Full Text] [Related]
34. IFNAR1 Controls Autocrine Type I IFN Regulation of PD-L1 Expression in Myeloid-Derived Suppressor Cells. Xiao W; Klement JD; Lu C; Ibrahim ML; Liu K J Immunol; 2018 Jul; 201(1):264-277. PubMed ID: 29752314 [TBL] [Abstract][Full Text] [Related]
35. The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy. Qian J; Wang C; Wang B; Yang J; Wang Y; Luo F; Xu J; Zhao C; Liu R; Chu Y J Neuroinflammation; 2018 Oct; 15(1):290. PubMed ID: 30333036 [TBL] [Abstract][Full Text] [Related]
37. Role of type I interferon signaling in human metapneumovirus pathogenesis and control of viral replication. Hastings AK; Erickson JJ; Schuster JE; Boyd KL; Tollefson SJ; Johnson M; Gilchuk P; Joyce S; Williams JV J Virol; 2015 Apr; 89(8):4405-20. PubMed ID: 25653440 [TBL] [Abstract][Full Text] [Related]
38. Perforin mediated apoptosis of cerebral microvascular endothelial cells during experimental cerebral malaria. Potter S; Chan-Ling T; Ball HJ; Mansour H; Mitchell A; Maluish L; Hunt NH Int J Parasitol; 2006 Apr; 36(4):485-96. PubMed ID: 16500656 [TBL] [Abstract][Full Text] [Related]
39. Type I interferons suppress CD4⁺ T-cell-dependent parasite control during blood-stage Plasmodium infection. Haque A; Best SE; Ammerdorffer A; Desbarrieres L; de Oca MM; Amante FH; de Labastida Rivera F; Hertzog P; Boyle GM; Hill GR; Engwerda CR Eur J Immunol; 2011 Sep; 41(9):2688-98. PubMed ID: 21674481 [TBL] [Abstract][Full Text] [Related]